Table 1 Baseline characteristics of the study population during pregnancy
From: Circulating acyl-CoA-binding protein/diazepam-binding inhibitor in gestational diabetes mellitus
Controls | GDM | p | |
|---|---|---|---|
N | 74 | 74 | |
ACBP (µg/l) | 29.1 (32.3) | 40.9 (40.0) | 0.215 |
Age (years) | 28.9 (4.5) | 31.0 (7.5) | 0.087 |
Gestational age at blood sampling (days) | 199 (40) | 202 (33) | 0.566 |
Gestational age at delivery (days) | 275 (15) | 273 (14) | 0.311 |
Infant birth weight (g) | 3360 (790) | 3400 (805) | 0.472 |
BMI (kg/m²) | 22.4 (6.7) | 24.5 (6.6) | 0.117 |
SBP (mmHg) | 125 (17) | 120 (20) | 0.336 |
DBP (mmHg) | 75 (13) | 73 (15) | 0.348 |
HbA1c (%) | 5.3 (0.6) | 5.4 (0.6) | 0.728 |
HbA1c (mmol/mol) | 34.4 (6.6) | 35.5 (6.6) | 0.728 |
Glucose 0 h(OGTT) (mmol/l) | 4.3 (0.5) | 4.5 (0.9) | < 0.001* |
Glucose 1 h(OGTT) (mmol/l) | 7.5 (1.6) | 10.1 (1.7) | < 0.001* |
Glucose 2 h(OGTT) (mmol/l) | 6.4 (1.8) | 8.7 (2.3) | < 0.001* |
FI (pmol/l) | 57.9 (38.4) | 70.6 (66.7) | 0.003* |
HOMA2-IR | 1.02 (0.68) | 1.29 (1.17) | 0.001* |
HOMA2-B | 135.3 (67.6) | 129.5 (88.9) | 0.991 |
Cholesterol (mmol/l) | 6.3 (1.8) | 6.7 (1.7) | 0.198 |
HDL cholesterol (mmol/l) | 1.9 (0.5) | 1.8 (0.8) | 0.417 |
LDL cholesterol (mmol/l) | 3.7 (1.6) | 4.1 (1.9) | 0.568 |
TG (mmol/l) | 2.0 (1.4) | 2.1 (1.3) | 0.451 |
FFA (mmol/l) | 0.5 (0.3) | 0.6 (0.3) | 0.047* |
Creatinine (µmol/l) | 49.0 (11.0) | 46.0 (11.3) | 0.086 |
hsCRP (mg/l) | 4.2 (4.3) | 4.0 (6.1) | 0.902 |